These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15176496

  • 1. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
    Sheth KK, Cook CK, Philpot EE, Prillaman BA, Witham LA, Faris MA, Klein KC, Rickard KA.
    Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
    [Abstract] [Full Text] [Related]

  • 2. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
    Vargas R, Dockhorn RJ, Findlay SR, Korenblat PE, Field EA, Kral KM.
    J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
    [Abstract] [Full Text] [Related]

  • 3. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
    Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D, Banerji D.
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
    [Abstract] [Full Text] [Related]

  • 4. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
    Bateman ED, Silins V, Bogolubov M.
    Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
    [Abstract] [Full Text] [Related]

  • 5. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 6. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 7. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T, Hubbell J, Cutler DL, Johnson-Levonas AO, Xu D, Kantesaria BS, Kim K, Miller SD.
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [Abstract] [Full Text] [Related]

  • 9. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D.
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [Abstract] [Full Text] [Related]

  • 10. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
    Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR.
    Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
    [Abstract] [Full Text] [Related]

  • 11. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT, Deans A, Mehta R, Sousa AR.
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [Abstract] [Full Text] [Related]

  • 12. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
    Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM.
    Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
    [Abstract] [Full Text] [Related]

  • 13. Fluticasone propionate in children with moderate asthma.
    Hoekstra MO, Grol MH, Bouman K, Stijnen T, Köeter GH, Kauffman HF, Gerritsen J.
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
    [Abstract] [Full Text] [Related]

  • 14. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
    Li JT, Goldstein MF, Gross GN, Noonan MJ, Weisberg S, Edwards L, Reed KD, Rogenes PR.
    J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011
    [Abstract] [Full Text] [Related]

  • 15. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
    Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.
    Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
    [Abstract] [Full Text] [Related]

  • 16. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
    Patel D, Ratner P, Clements D, Wu W, Faris M, Philpot E.
    Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
    [Abstract] [Full Text] [Related]

  • 17. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 19. Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers.
    Bachert C, Lukat KF, Lange B.
    Clin Exp Allergy; 2004 Jan; 34(1):85-90. PubMed ID: 14720267
    [Abstract] [Full Text] [Related]

  • 20. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.